RPS6KA1 and breast carcinoma: Inhibition and/or silencing of RSK1 and RSK2 reduce proliferation, survival, migration, and invasion of breast cancer cells, especially TNBC cells, and prevent breast cancer stem cell growth, underscoring their role in breast tumorigenesis [6–13].